Changes in Health Care Costs, Survival, and Time Toxicity in the Era of Immunotherapy and Targeted Systemic Therapy for Melanoma.
JAMA Dermatol
; 159(11): 1195-1204, 2023 11 01.
Article
in En
| MEDLINE
| ID: mdl-37672282
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Melanoma
Type of study:
Health_economic_evaluation
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
Country/Region as subject:
America do norte
Language:
En
Journal:
JAMA Dermatol
Year:
2023
Document type:
Article
Affiliation country:
Canada